John F Rex bought $5.0M of UnitedHealth Group Incorporated (UNH)
Executed May 16 2025, disclosed May 16 2025, the same day.
Over the 21 trading sessions from the disclosed entry session (May 16 2025), the stock returned +10.9% (delay-adjusted); from the execution session (May 16 2025), +10.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
John F Rex (President & CFO) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in UnitedHealth Group Incorporated (UNH). Across 1 priced purchase filing, the average 21-session return was +10.9% from execution and +10.9% from disclosure (delay-adjusted; derived). The largest single filing was $5.0M of UNH (17,175 sh × $291.12, as filed), executed May 16 2025.
Healthcare · UnitedHealth Group Incorporated operates as a health care company in the United States and internationally
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→